发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report UEGW 2022最新文献

筛选
英文 中文
Etrasimod reduces adaptive immune cells in the periphery in UC 伊特拉西莫德减少UC周围的适应性免疫细胞
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/a3b9f503
S. Kammerer
{"title":"Etrasimod reduces adaptive immune cells in the periphery in UC","authors":"S. Kammerer","doi":"10.55788/a3b9f503","DOIUrl":"https://doi.org/10.55788/a3b9f503","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125803395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upadacitinib for CD: remarkable efficacy in induction therapy Upadacitinib治疗CD:诱导治疗效果显著
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/c236bca5
S. Kammerer
{"title":"Upadacitinib for CD: remarkable efficacy in induction therapy","authors":"S. Kammerer","doi":"10.55788/c236bca5","DOIUrl":"https://doi.org/10.55788/c236bca5","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114590101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IL-23 inhibition reduces inflammatory biomarkers in pre-treated UC IL-23抑制可降低预处理UC的炎症生物标志物
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/6ced90ad
S. Kammerer
{"title":"IL-23 inhibition reduces inflammatory biomarkers in pre-treated UC","authors":"S. Kammerer","doi":"10.55788/6ced90ad","DOIUrl":"https://doi.org/10.55788/6ced90ad","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129462630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etrasimod shows advantage over placebo in UC 伊特拉西莫德在UC中比安慰剂有优势
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/3d2f53d9
S. Kammerer
{"title":"Etrasimod shows advantage over placebo in UC","authors":"S. Kammerer","doi":"10.55788/3d2f53d9","DOIUrl":"https://doi.org/10.55788/3d2f53d9","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127152348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pivotal results of etrolizumab for CD partly disappointing etrolizumab治疗CD的关键结果部分令人失望
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/3cac1868
S. Kammerer
{"title":"Pivotal results of etrolizumab for CD partly disappointing","authors":"S. Kammerer","doi":"10.55788/3cac1868","DOIUrl":"https://doi.org/10.55788/3cac1868","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121153237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some patients with limited CD may benefit from an early surgical intervention 一些有限乳糜泻患者可能从早期手术干预中获益
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/0eb0b5e4
S. Kammerer
{"title":"Some patients with limited CD may benefit from an early surgical intervention","authors":"S. Kammerer","doi":"10.55788/0eb0b5e4","DOIUrl":"https://doi.org/10.55788/0eb0b5e4","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121130932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maintained symptom control with mirikizumab in UC 米利珠单抗维持UC患者的症状控制
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/9c1c1003
S. Kammerer
{"title":"Maintained symptom control with mirikizumab in UC","authors":"S. Kammerer","doi":"10.55788/9c1c1003","DOIUrl":"https://doi.org/10.55788/9c1c1003","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128728697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Better results for vedolizumab in early CD vedolizumab治疗早期CD效果更好
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/2603d7ef
S. Kammerer
{"title":"Better results for vedolizumab in early CD","authors":"S. Kammerer","doi":"10.55788/2603d7ef","DOIUrl":"https://doi.org/10.55788/2603d7ef","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116730453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Favourable maintenance rates for risankizumab also in delayed responders with CD 利桑单抗在CD延迟反应患者中的维持率也较好
Medicom Conference Report UEGW 2022 Pub Date : 2022-12-01 DOI: 10.55788/6205580f
S. Kammerer
{"title":"Favourable maintenance rates for risankizumab also in delayed responders with CD","authors":"S. Kammerer","doi":"10.55788/6205580f","DOIUrl":"https://doi.org/10.55788/6205580f","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121873640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UEGW 2022 Highlights Podcast UEGW 2022亮点播客
Medicom Conference Report UEGW 2022 Pub Date : 2022-10-13 DOI: 10.55788/b5118203
S. Kammerer
{"title":"UEGW 2022 Highlights Podcast","authors":"S. Kammerer","doi":"10.55788/b5118203","DOIUrl":"https://doi.org/10.55788/b5118203","url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"129 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128703940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信